G.H. Blijham
- Oncology top 1%
- Cancer Treatment and Pharmacology 16
- Colorectal Cancer Treatments and Studies 15
- Bone health and treatments 7
- Otorhinolaryngology top 1%
- Cancer Research top 2%
- Breast Cancer Treatment Studies 8
- Cancer Genomics and Diagnostics 7
-
- Gastric Cancer Management and Outcomes 12
- Lung Cancer Treatments and Mutations 9
- Hepatology top 5%
-
- Radiopharmaceutical Chemistry and Applications 7
G.H. Blijham
83 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 132
- Oncology 2.3k
- Otorhinolaryngology 259
- Cancer Research 738
- Pulmonary and Respiratory Medicine 1.2k
- Hepatology 242
Countries citing papers authored by G.H. Blijham
This map shows the geographic impact of G.H. Blijham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.H. Blijham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.H. Blijham more than expected).
Fields of papers citing papers by G.H. Blijham
This network shows the impact of papers produced by G.H. Blijham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.H. Blijham. The network helps show where G.H. Blijham may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G.H. Blijham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 5 | |
| 2 | 2010 | 63 | |
| 3 | 2003 | 62 | |
| 4 | 2002 | 356 | |
| 5 | 2001 | 10 | |
| 6 | 2000 | 14 | |
| 7 | 2000 | 5 | |
| 8 | 1999 | 142 | |
| 9 | 1998 | 34 | |
| 10 | 1997 | 26 | |
| 11 | 1997 | 7 | |
| 12 | 1996 | 14 | |
| 13 | 1995 | 16 | |
| 14 | Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer | 1994 | 162 |
| 15 | 1993 | 35 | |
| 16 | 1991 | 33 | |
| 17 | 1987 | 1 | |
| 18 | 1987 | 162 | |
| 19 | 1986 | 1 | |
| 20 | Primary chemotherapy in cancer medicine | 1985 | 32 |
About G.H. Blijham
G.H. Blijham is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Pathology and Forensic Medicine, having authored 88 papers that have together received 4.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (16 papers), Colorectal Cancer Treatments and Studies (15 papers), Gastric Cancer Management and Outcomes (12 papers), Lung Cancer Treatments and Mutations (9 papers), Breast Cancer Treatment Studies (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Cancer Genomics and Diagnostics (7 papers) and Bone health and treatments (7 papers). The work is most often cited by research in Oncology (2.3k citations), Otorhinolaryngology (259 citations), Cancer Research (738 citations), Pulmonary and Respiratory Medicine (1.2k citations) and Hepatology (242 citations). G.H. Blijham has collaborated with scholars based in Netherlands, Belgium and Germany. Frequent co-authors include B. Schütte, M. Reynders, Fred T. Bosman, Gerard Groenewegen, G.J. Hordijk, Wynand J.G. Ros, J.R.J. de Leeuw, J.A.M. Winnubst, Alexander de Graeff and Harry Bleiberg. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology, British Journal of Cancer and Cytometry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.